Does DEFIBROTIDE Cause Multiple organ dysfunction syndrome? 372 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 372 reports of Multiple organ dysfunction syndrome have been filed in association with DEFIBROTIDE (DEFITELIO). This represents 10.0% of all adverse event reports for DEFIBROTIDE.
372
Reports of Multiple organ dysfunction syndrome with DEFIBROTIDE
10.0%
of all DEFIBROTIDE reports
337
Deaths
125
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From DEFIBROTIDE?
Of the 372 reports, 337 (90.6%) resulted in death, 125 (33.6%) required hospitalization, and 46 (12.4%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFIBROTIDE. However, 372 reports have been filed with the FAERS database.
What Other Side Effects Does DEFIBROTIDE Cause?
Off label use (1,323)
Venoocclusive disease (576)
Death (463)
Venoocclusive liver disease (355)
Intentional product use issue (201)
Hypotension (169)
Haemorrhage (156)
Sepsis (143)
Acute graft versus host disease (140)
Gastrointestinal haemorrhage (125)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which DEFIBROTIDE Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
DEFIBROTIDE vs DEFLAZACORT
DEFIBROTIDE vs DEGARELIX
DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE
DEFIBROTIDE vs DELAMANID
DEFIBROTIDE vs DELANDISTROGENE MOXEPARVOVEC-ROKL